Evidence map›Paper›PMID 28449692›Full record

Observational studyArthritis research & therapy2017

Clinical and demographic factors associated with change and maintenance of disease severity in a large registry of patients with rheumatoid arthritis.

George W Reed, David H Collier, Andrew S Koenig, Katherine C Saunders, Dimitrios A Pappas, Heather J Litman, Joel M Kremer, Sameer Kotak

Abstract readObservational Study
In one paragraph

Observational study in Arthritis research & therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

George W ReedUniversity of Massachusetts Medical School, 55 Lake Ave North, Worcester, MA, 01605, USA. George.Reed@umassmed.edu.
David H CollierAmgen Inc., Thousand Oaks, CA, USA.
Andrew S KoenigPfizer Inc., Collegeville, PA, USA.
Katherine C SaundersCorrona LLC, Southborough, MA, USA.
Dimitrios A PappasCorrona LLC, Southborough, MA, USA.
Heather J LitmanCorrona LLC, Southborough, MA, USA.
Joel M KremerCorrona LLC, Southborough, MA, USA.
Sameer KotakPfizer Inc., Collegeville, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe examined models to predict disease activity transitions from moderate to low or severe and associated factors in patients with rheumatoid arthritis (RA).

methodsData from RA patients enrolled in the Corrona registry (October 2001 to August 2014) were analyzed. Clinical Disease Activity Index (CDAI) definitions were used for low (≤10), moderate (>10 and ≤22), and severe (>22) disease activity states. A Markov model for repeated measures allowing for covariate dependence was used to model transitions between three (low, moderate, severe) states and estimate population transition probabilities. Mean sojourn times were calculated to compare length of time in particular states. Logistic regression models were used to examine impacts of covariates (time between visits, chronological year, disease duration, age) on disease states.

resultsData from 29,853 patients (251,375 visits) and a sub-cohort of 9812 patients (46,534 visits) with regular visits (every 3-9 months) were analyzed. The probability of moving from moderate to low or severe disease by next visit was 47% and 18%, respectively. Patients stayed in moderate disease for mean 4.25 months (95% confidence interval: 4.18-4.32). Transition probabilities showed 20% of patients with low disease activity moved to moderate or severe disease within 6 months; >35% of patients with moderate disease remained in moderate disease after 6 months. Results were similar for the regular-visit sub-cohort. Significant interactions with prior disease state were seen with chronological year and disease duration.

conclusionA substantial proportion of patients remain in moderate disease, emphasizing the need for treat-to-target strategies for RA patients.

Indexed as

Markov ChainsRegistriesSeverity of Illness IndexAdultAgedArthritis, RheumatoidCohort StudiesFemaleHumansMaleMiddle AgedProspective StudiesClinical Disease Activity IndexDisease activityMarkov modelPredictionRheumatoid arthritis

Identifiers

PMID28449692
PMCPMC5406915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.